108 related articles for article (PubMed ID: 1980342)
21. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
[TBL] [Abstract][Full Text] [Related]
22. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
[TBL] [Abstract][Full Text] [Related]
23. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
24. Allele loss on chromosome 11p is associated with poor survival in ovarian cancer.
Eccles DM; Gruber L; Stewart M; Steel CM; Leonard RC
Dis Markers; 1992; 10(2):95-9. PubMed ID: 1360888
[TBL] [Abstract][Full Text] [Related]
25. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract][Full Text] [Related]
26. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the association of inherited predisposition to breast cancer with c-Ha-ras-1 oncogene alleles].
Nefedov MD; Gar'kavtsev IV; Rogaev EI
Genetika; 1990 Dec; 26(12):2226-31. PubMed ID: 2086347
[TBL] [Abstract][Full Text] [Related]
28. Restriction fragment length polymorphism of the c-Ha-ras-1 proto-oncogene as a marker of genome alterations and susceptibility to the development of some human carcinomas.
Knyazev PG; Nikiforova IF; Serova OM; Novikov LB; Pluzhnikova GF; Abramov AM; Seitz JF
Haematol Blood Transfus; 1989; 32():433-5. PubMed ID: 2576239
[No Abstract] [Full Text] [Related]
29. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
[TBL] [Abstract][Full Text] [Related]
30. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
31. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
Sakamoto T; Nomura N; Mori H; Wake N
Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
[TBL] [Abstract][Full Text] [Related]
32. Ha-ras-1 alleles in Norwegian lung cancer patients.
Ryberg D; Tefre T; Ovrebø S; Skaug V; Stangeland L; Naalsund A; Baera R; Børresen AL; Haugen A
Hum Genet; 1990 Nov; 86(1):40-4. PubMed ID: 1979305
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the estrogen receptor gene structure in human breast cancer.
Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
[TBL] [Abstract][Full Text] [Related]
34. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
[TBL] [Abstract][Full Text] [Related]
35. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
Cheng JQ; Crépin M; Hamelin R
C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
[TBL] [Abstract][Full Text] [Related]
36. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
Behn M; Qun S; Pankow W; Havemann K; Schuermann M
Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
[TBL] [Abstract][Full Text] [Related]
37. Specific H-Ras minisatellite alleles in breast cancer susceptibility.
Gosse-Brun S; Sauvaigo S; Daver A; Page M; Lortholary A; Larra F; Bignon YJ; Bernard-Gallon D
Anticancer Res; 1999; 19(6B):5191-6. PubMed ID: 10697533
[TBL] [Abstract][Full Text] [Related]
38. [Study on Ha-ras RFLPs in gastric carcinoma and normal tissue DNAs of Chinese individuals].
Shan X; Yan M; Huang Y; Mao Y; Wang S; Zhao S
Yi Chuan Xue Bao; 1990; 17(2):154-60. PubMed ID: 1978686
[TBL] [Abstract][Full Text] [Related]
39. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma.
Seifart C; Lin HM; Seifart U; Plagens A; DiAngelo S; von Wichert P; Floros J
Clin Genet; 2005 Aug; 68(2):128-36. PubMed ID: 15996209
[TBL] [Abstract][Full Text] [Related]
40. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
